Prognostic impact of HER2-low expression in triple-negative breast cancer of high-grade special histological type and no special type.

Prognostic impact of HER2-low expression in triple-negative breast cancer of high-grade special histological type and no special type.

Show other versions (1)

Interest in HER2-low breast cancer has grown in recent years due to advancements in novel anti-HER2 antibody-drug conjugates. This study examined the impact of HER2-low expression on survival outcomes in triple-negative breast cancer (TNBC) of high-grade special histological type (ST) and no special...

Full description

Saved in:
Bibliographic Details
Main Authors: Claudia Grosse, Petar Noack, Alexandra Grosse, Heike Kathleen Schwarz, Peter Schrenk, Heike Frauchiger-Heuer, Rupert Langer, Zsuzsanna Varga
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0325715
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items